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http:WHAT THIS PAPER ADDS
In the present paper, a novel technique is described for the proximalization of arteriovenous inﬂow without the
use of a prosthetic graft. This is a development of a well-known procedure, but has not been reported before.
This could offer a welcome alternative approach for the management of severe access-related ischemia, even
though it is not feasible for all patients. The technique provides equivalent results to other procedures, but lacks
the typical drawbacks of ligation of healthy vessels, a high rate of recurrent ischemia, and the use of prosthetic
grafts.Objective: Proximalization of arteriovenous inﬂow (PAI) is an established technique for treating patients with
access-induced hand ischemia. However, a prosthetic graft, used as arterial inﬂow, could minimize the beneﬁts of
a purely native ﬁstula. In this study, a new PAI technique is reported, which avoids the use of prosthetic grafts in
patients with matured basilic and cephalic veins.
Patients and methods: Eight patients (seven men, one woman; mean age 62 (45e82) years old) with grade III/IV
critical dialysis access-related ischemia (DARI) and with a pre-existing Gracz ﬁstula underwent an operation using
modiﬁed PAI. The basilic and cephalic veins were preoperatively matured. During the operation, the former
arteriovenous anastomosis was closed and the basilic vein was used as arterial inﬂow.
Results: All procedures were technically successful. All patients but one could be discharged with a warm,
neurologically improved extremity with a signiﬁcant reduction in pain. After a mean follow-up of 43.5 (0e52)
months, there were no recurrent steal symptoms and all necrotic hand lesions healed. Two patients died during
the follow-up, but with well-functioning ﬁstulae. One ﬁstula failed during follow-up and one further ﬁstula was
ligated because of chronic neurological damage, which was not improved after the PAI procedure. Four AVFs are
still available for hemodialysis.
Conclusions: The modiﬁcation of the PAI technique with a basilic vein as presented here showed similar results
to the original PAI procedure. This new procedure does not require prosthetic grafts as in the original PAI
technique or a central venous catheter and leads to the enlargement of the puncture site as a result of the
superﬁcialization of the basilic vein. Therefore, it is believed that this new technique could be a good option for
those patients with matured cephalic and basilic veins who suffer from severe access-related ischemia.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Dialysis access-related ischemia (DARI) is a well-known and
devastating complication of access surgery. It occurs in up
to 10%1e4 of patients after creation of a native or prosthetic
arteriovenous ﬁstula. During the past four decades, severalresponding author. V. Matoussevitch, Department of Vascular Sur-
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//dx.doi.org/10.1016/j.ejvs.2014.07.003factors leading to the onset of DARI have been identiﬁed
and different treatment strategies have been developed.5e8
Since 2006, a new approach, proximalization of the
arteriovenous anastomosis (PAI), as described by Zanow
et al.,6 has appeared to be very successful in the treatment
of dialysis-induced ischemia, with at least as good results as
those observed after distal revascularization-interval liga-
tion (DRIL). The PAI procedure does not require the ligation
of a healthy artery, as is necessary in DRIL surgery. In
addition, a bypass to the downstream arteries is not
needed. With the PAI technique, the arterial inﬂow origi-
nates from the proximal brachial, the axillary, or even from
the subclavian artery via an anastomosis with a PTFE graft.
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with the potential risk of graft infection and subsequent life-
threatening problems.
In the present paper, a new approach is described as a
modiﬁcation of the PAI procedure. This approach is based
on the use of matured basilic and cephalic veins, as is often
the case in patients with Gracz type ﬁstulae. Furthermore, it
preserves the advantages of the original PAI idea (proximal/
central arterial inﬂow location) with the use of a native
vein, thus replacing the use of graft material.MATERIALS AND METHODS
This retrospective analysis of prospectively collected data
from January 1, 2008 to May 31, 2013 includes eight pa-
tients with different degrees of DARI symptoms (according
to the Tordoir classiﬁcation4) after the vascular access
procedure, and who fulﬁlled the following inclusion criteria:
persistence of clinically signiﬁcant symptoms such as pain at
rest or pain during hemodialysis sessions, inadequate
treatment or control with the usual medication, neurolog-
ical symptoms, and tissue damage/loss, e.g. gangrene.
Furthermore, only patients who had previously received a
Gracz type AV ﬁstula (Fig. 1)9,10 with appropriately matured
upper arm cephalic and basilic veins were included in the
study. Patients gave written informed consent prior to
surgery.
All patients were seen by team members of our Inter-
disciplinary Vascular Access Centre. A vascular surgeon and
a nephrologist performed a meticulous clinical examination,
followed by duplex ultrasound. The ﬂow measurements
were performed preoperatively on the brachial artery
(along the middle third of the brachial artery in the upper
arm), which approximates to the ﬁstula ﬂow and is rec-
ommended by some authors.11,12 The presence of a
matured basilic vein had to be conﬁrmed sonographically.
The wrist-brachial index was calculated as for ABI. In the
case of clinically relevant DARI, transfemoral arteriography
was routinely performed on the affected upper extremity
with and without compression of the vascular access
(Fig. 2).
All operations were performed under general anesthesia.
Hemodynamic changes during the operation wereFigure 1. Gracz type ﬁstula modiﬁed by K. Konner: (1) cephalic
vein, (2) brachial artery, (3) basilic vein, (4) anastomosis with
perforating vein, (5) elbow level, (6) cephalic antebrachial vein.monitored by direct arterial pressure monitoring via radial
or brachial cannulation on the contralateral arm and/or by
non-invasive measurement of the blood pressure.Technique of PAI with basilic vein (PAI-bas, Fig. 3)
Through a 4e5 cm incision on the proximal arm close to the
axilla, the proximal segments of the brachial artery and
basilic vein were dissected free. A new small arteriovenous
anastomosis of 4e5 mm was created with running suture
(5-0 or 6-0) using the vein-end to artery-side technique.
After removing the clamps from the brachial artery and the
basilic vein, the incision was extended distally. All hemo-
dynamically relevant arteriovenous ﬁstulae between the
arterialized basilic vein and the brachial veins were ligated
and divided. The former arteriovenous anastomosis be-
tween the perforating vein and cubital artery below the
elbow was ligated. The venous valves along the basilic vein
were destroyed with an expandable valvulotome
(LeMaitre-Valvulotome), which was inserted through the
perforating vein. The basilic vein was superﬁcialized and
transposed subcutaneously, along the biceps muscles, to
lengthen the puncture site.
Intraoperative ﬂow measurements (see Table 3) were
completed at the end of the operation. These were per-
formed after establishing the stable ﬂow values on the
proximal brachial/distal axillary artery just above the anas-
tomosis. Handheld or on-clamp appropriately sized ultra-
sound probes were used with the transit-time method
(VeriQ, MediStim AS, Oslo, Norway). Blood pressure
adjustment during the ﬂow measurement was in accor-
dance with normal blood pressure before the operation.
After the operation, the patients were examined clinically
and with color enhanced Doppler ultrasonography. The
(new) palpability of radial and/or ulnar pulses as well as
remission of ischemic symptoms were assessed and
documented.
RESULTS
From January 2008 to June 2013, eight patients were
treated surgically for dialysis-associated ischemia with a
modiﬁed PAI procedure; during this period, a further 17
patients underwent PAI operations using PTFE grafts. The
demographic details are shown in Table 1. The intra-
operative technical success rate was 100%. The median
follow-up was 43.5 (range 0e52) months. The pre/post-
operative status and respective outcomes are listed in
Table 2. The measured ﬂow values pre- and postoperatively
as well as the deﬁned ﬂow reduction are summarized in
Table 3.
A functioning AV ﬁstula with restored peripheral arterial
perfusion was achieved in all eight patients at the end of
the operation. One patient died of cardiovascular failure 8
days after surgery giving a 30-day mortality of 1 of 8.
Another patient died 5 months after surgery, also because
of cardiovascular failure. Both these patients died with well-
functioning ﬁstulae and without clinical signs of DARI. Of
the remaining six patients, ﬁve are still on HD and one
Figure 2. Transfemoral angiogram without (A) and with (B) ﬁstula compression.
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patient, initially diagnosed as having stage III4 DARI and
early trophic disorders, recovered completely. However, he
suffered from ﬁstula occlusion after a cannulation incident,
with extended hematoma 14 months after the PAI proce-
dure. The PAI ﬁstula was not revised and he received a new
Gracz ﬁstula on the contralateral right forearm. This ﬁstula
was used for HD until renal transplantation 2 years later.
In one patient, the ﬁstula had to be abandoned 1 month
after the PAI procedure. This patient presented preopera-
tively with severe wrist and digital pain. She also com-
plained of persistent neuropathic pain associated with
median nerve injury, which had occurred during the initial
ﬁstula creation in another hospital. Despite signiﬁcant initial
improvement in pain attacks and with palpable radial pulse
after the PAI procedure, the neuropathic pain did not
signiﬁcantly improve as expected. Therefore, it was decided
to ligate the ﬁstula. The patient was then treated with
neuroleptic drugs and is still on HD using a tunneled
catheter.
Another patient has a well-functioning PAI ﬁstula and is
completely free from pain. However, she is being dialysed
using an indwelling catheter, because of her fear of the
potential pain of cannulation. Three other patients areFigure 3. PAI with basilic vein: (1) cephalic vein, (2) new anasto-
mosis brachio-basilic, (3) brachial artery, (4) basilic vein, (5) elbow
level, (6) perforating vein ligated/insertion place of valvulotome.being dialysed via the modiﬁed PAI ﬁstula without further
problems.
DISCUSSION
The incidence of DARI has remained relatively constant in
recent years, despite the continuous increases in the
number of patients at risk: diabetics, patients with periph-
eral arterial disease and a history of multiple previous ac-
cess procedures. This may correspond to as many as 10%1e4
of all patients undergoing AV access surgery.
At the authors’ institution, about 250 surgical access
procedures are performed annually, with about 4e5% of
patients with DARI (unpublished data). The PAI technique,
ﬁrst described in 2006 by Zanow et al.6 is safe and easy to
perform. This technique includes ligation of the preexisting
arteriovenous anastomosis and implantation of a PTFE graft
with arterial inﬂow from the axillar artery. There have only
been two publications on the PAI technique with mid- to
long-term follow-up.6,13
Zanow et al.6 reported 30 patients treated with PAI. The
success rate (complete regression of symptoms) was 84%
and only mild rest symptoms in 13% of patients were re-
ported. These excellent results were also conﬁrmed in a
study published by Thermann et al.13 They reported an 82%
success rate in 40 patients. These data demonstrate nearly
identical rates of symptom relief to the well-known results
of the DRIL procedure.5,14,15 However, whereas the DRIL
procedure requires ligation of a patent brachial artery,5 PAI
avoids this potentially harmful step, which is associated
with a high risk of signiﬁcant deterioration in distal arterial
perfusion of the forearm and wrist.6
The results of this study conﬁrm the positive experience
with the PAI technique. In this small cohort of eight pa-
tients, substantial improvement of DARI was achieved in all
but one patient. In this patient, signiﬁcant improvement in
pain was found after the PAI procedure. However, the pre-
existing neural damage led to permanent neural sensations
and thus to abandonment of the ﬁstula.
The most important advantage of the present PAI
modiﬁcation compared with the original PAI procedure is
Table 1. Patient characteristics.
Patient Age Sex DARI status Degree
acc. to
Tordoir
Previous
ﬁstula
Diabetes Body
mass
index
Peripheral arterial
occlusive disease
(PAOD)
Coronary heart
disease (CHD)
Hypertension Died
1 63.0 m Necrosis dig. 2-3 4 4  26.5 þ  þ 
2 74.0 m Rest pain 3 2 þ 40.9   þ 
3 45.0 m Necrosis dig 1 4 2 þ 19.6 þ þ  þ
4 81.0 f Rest pain 3 7  29.0 þ  þ 
5 62.0 m Rest pain 3 4 þ 27.0   þ 
6 54.0 f Necrosis dig 3-5 4 2 þ 29.4  þ þ 
7 66.0 m Necrosis dig 3-5 4 1  15.7    þ
8 50.0 m Rest pain and high
ﬂow >4 L/min
3 1 þ 34.9   þ 
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avoid or minimize the important drawbacks of original PAI,
which are graft infection and graft occlusion.
The close correlation between the use of grafts in access
surgery and infection rates is well known. Some published
studies report infection rates of up to 20% for AVGs
compared with about 5% for AV ﬁstulae.16e18 Zanow re-
ported about 1/30 (3%)6 and Thermann about 3/40 (7.5%; 1
graft infection and 2 perigraft reaction)13 infected grafts.
Although the published graft infection rates in both PAI
studies were very low, these results could be the conse-
quence of the very great experience of both vascular access
centers.
With the present modiﬁed PAI technique, in which the
grafts are replaced with a basilic vein, there were no cases
of infection and thus no case in which infection led to ﬁstula
loss.
Graft occlusion occurs frequently and is, in most cases,
caused by intimal hyperplasia at the graft-vein anastomosis.
This leads to a high rate of repeated procedures with pro-
longed in-hospital stay and high patient morbidity.
Zanow’s patency rates after 12 and 36 months were 87%
and 67%, respectively.6 Thermann et al.’s results were
slightly inferior (77% and 62% patency rates after 6 and 12
months, respectively13). A subgroup analysis revealed the
inferior performance of non-heparinized versus heparinized
grafts, with 31% versus 75%, respectively, after 12
months.13
The functional patency of the modiﬁed PAI ﬁstulas was
similar to that of Zanow. However, KaplaneMeier analysis
of a small cohort cannot be used. Only one patient suffered
from an access occlusion after bleeding and major hema-
toma because of failed cannulation.Table 2. Change of digital-brachial index and pulse status by PAI with
Patient Angiogram Digital-brachial index
Without/with compression Pre PAI Post PAI
1 e/RA 0.2 1.0
2 e/RA þ UA 0.0 1.0
3 e/RA 0.0 na
4 e/RA þ UA 0.3 0.9
5 e/RA 0.0 0.9
6 e/RA 0.2 0.8
7 RA/RA þ UA 0.0 na
8 e/UA 0.5 1.0
RA ¼ radial artery; UA ¼ ulnar artery; PAI ¼ proximalization of arteriovFrom this point of view, the use of native veins might be
more effective in terms of long-term patency as well as in
avoiding infections. The additional positive effect of this
modiﬁcation is the increase in the area available for punc-
ture. The superﬁcialization and transposition of the matured
basilic vein subcutaneously to the biceps muscles enabled
the use of an additional cannulation site 4e6 weeks after
surgery.
An important limitation of the PAI-basilic-vein-
modiﬁcation is the requirement that both the upper arm
cephalic and basilic veins must be sufﬁciently matured. For
this reason, surgery is feasible only in a subset of patients.
An alternative procedure for patients with well-matured
cephalic and basilic veins and high ﬂow ﬁstula was pub-
lished by Vaes et al. in 2012.19 This technically very simple
procedure consists of the ligation of the side branches and
then of one of the two matured veins, usually the basilic.
The concept of an increase in peripheral resistance as a
consequence of limited outﬂow is plausible. However, in the
present limited cohort, the reduction in intraoperative ﬂow
by clamping one of the two upper arm veins failed to reach
the expected and desired volume. For this reason, this
technique was not adopted.
In addition, ligation of the median basilic vein can, in
principle, lead to the complete loss of the matured vein or
even of the AV ﬁstula in patients with irreparable cephalic
vein occlusion.
Another alternative procedure for patients with hand
ischemia that uses the basilic vein is the technique
described by Jennings et al.2,20 However, their ﬁstulae are
primary ﬁstulae, originating from the axillar artery, and
could not be used immediately because of non-matured
veins. These patients should not be on HD or need a CVC.basilic vein (PAI-bas).
Pulse RA Pulse UA HD currently
Pre PAI Post PAI Pre PAI Post PAI
0 1 0 0 þ
0 1 0 1 þ
0 1 0 0 Died
0 1 0 0 þ
0 1 0 0 Transplanted
0 1 0 0 CVC
0 1 0 0 Died
0 0 0 1 þ
enous inﬂow; CVC ¼ central venous catheter; HD ¼ hemodialysis.
Table 3. Change of brachial ﬂow by PAI with basilic vein (PAI-bas).
Patient Flow pre PAI
(mL/min)
Flow post PAIa
(mL/min)
Flow reduction
(%)
1 1700 650 162
2 1800 900 100
3 1200 780 53.8
4 1250 730 71.2
5 1500 900 66.7
6 900 650 38.5
7 1400 500 180
8 4500 950 374
PAI ¼ proximalization of arteriovenous inﬂow.
a Intraoperative measurement.
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important for a subgroup of patients, it requires one-step
superﬁcialization/transposition of the basilic vein, which
probably gives poorer results in terms of patency than does
the transposition of matured veins.21e23
In conclusion, a new approach is presented for manage-
ment of DARI. The new variant is a modiﬁcation of the well-
known PAI technique, but surgery is performed exclusively
using native veins. This modiﬁcation may not be feasible in
all patients, as it requires two equally matured veins. This
point must be considered before deciding whether the new
procedure is advantageous for an individual patient.
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